NNNN
Anbio Biotechnology
6.20$
+1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 99.6% | 98.0% | 100.0% | |
| 85.1% | 50.9% | 61.3% | 62.2% | 25.7% | |
| 85.1% | 62.1% | 61.3% | 62.2% | 39.4% | |
| 14.6% | 0.0% | 11.9% | 5.6% | 12.1% | |
| 0.0% | 2.5% | 0.0% | – | – | |
| 48.4% | 10.1% | 6.3% | 9.1% | 0.3% | |
| 48.4% | 10.1% | 6.3% | 9.1% | 0.3% | |
| 38.4% | 10.1% | 5.2% | 8.6% | 0.0% | |
| 51.6% | 89.9% | 93.7% | 90.9% | 99.7% | |
| 51.6% | 89.9% | 93.6% | 90.8% | 78.0% | |
| 2,034.3% | 1,030.9% | 1,187.6% | 223.5% | 145.1% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.